Name | Lansoprazole Sulfone |
---|---|
Synonyms |
Lansoprazole Related Compound A
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfonyl]-1H-benzimidazole 1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]- 2-({[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl}sulfonyl)-1H-benzimidazole 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole |
Description | Lansoprazole sulfone (AG-1813) is an orally active and selective inhibitor of H+, K+-ATPase. Lansoprazole sulfone can significantly stimulates gastric acid secretion by inhibiting H+, K+-ATPase. Lansoprazole sulfone has potential applications in duodenal ulcer, gastric ulcer, gastroesophageal reflux disease and Zolinger Ellison disease[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 555.6±60.0 °C at 760 mmHg |
Melting Point | 207ºC(dec.) |
Molecular Formula | C16H14F3N3O3S |
Molecular Weight | 385.361 |
Flash Point | 289.8±32.9 °C |
Exact Mass | 385.070801 |
PSA | 93.32000 |
LogP | 4.46 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.581 |
RIDADR | NONH for all modes of transport |
---|